- Home
- TRVI vs CLOV Comparison
TRVI vs CLOV Comparison
Compare TRVI & CLOV Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- TRVI
- CLOV
- Stock Information
- Founded
- TRVI 2011
- CLOV 2014
- Country
- TRVI United States
- CLOV United States
- Employees
- TRVI N/A
- CLOV N/A
- Industry
- TRVI Biotechnology: Pharmaceutical Preparations
- CLOV Medical Specialities
- Sector
- TRVI Health Care
- CLOV Health Care
- Exchange
- TRVI Nasdaq
- CLOV Nasdaq
- Market Cap
- TRVI 1.4B
- CLOV 1.3B
- IPO Year
- TRVI 2019
- CLOV N/A
- Fundamental
- Price
- TRVI $10.91
- CLOV $2.69
- Analyst Decision
- TRVI Strong Buy
- CLOV Strong Buy
- Analyst Count
- TRVI 9
- CLOV 3
- Target Price
- TRVI $20.72
- CLOV $4.37
- AVG Volume (30 Days)
- TRVI 1.6M
- CLOV 11.6M
- Earning Date
- TRVI 11-10-2025
- CLOV 11-04-2025
- Dividend Yield
- TRVI N/A
- CLOV N/A
- EPS Growth
- TRVI N/A
- CLOV N/A
- EPS
- TRVI N/A
- CLOV N/A
- Revenue
- TRVI N/A
- CLOV $1,773,564,000.00
- Revenue This Year
- TRVI N/A
- CLOV $40.52
- Revenue Next Year
- TRVI N/A
- CLOV $31.46
- P/E Ratio
- TRVI N/A
- CLOV N/A
- Revenue Growth
- TRVI N/A
- CLOV N/A
- 52 Week Low
- TRVI $2.36
- CLOV $2.12
- 52 Week High
- TRVI $11.83
- CLOV $4.87
- Technical
- Relative Strength Index (RSI)
- TRVI 57.30
- CLOV 40.31
- Support Level
- TRVI $10.22
- CLOV $2.59
- Resistance Level
- TRVI $11.82
- CLOV $3.72
- Average True Range (ATR)
- TRVI 0.55
- CLOV 0.26
- MACD
- TRVI -0.07
- CLOV -0.06
- Stochastic Oscillator
- TRVI 37.95
- CLOV 11.78
About TRVI Trevi Therapeutics Inc.
Trevi Therapeutics Inc is a clinical-stage biopharmaceutical company focused on the development and commercialization of the investigational therapy Haduvio (oral nalbuphine ER) for the treatment of chronic cough in adults with idiopathic pulmonary fibrosis, or IPF, and other chronic cough indications, and for the treatment of prurigo nodularis. Haduvio is an oral extended-release formulation of nalbuphine.
About CLOV Clover Health Investments Corp.
Clover Health Investments Corp is a healthcare technology company. It focuses on empowering Medicare physicians to proactively manage chronic diseases through its proprietary software platform, Clover Assistant. This cloud-based solution provides personalized insights to physicians, enabling early detection and management of chronic conditions. It operates in one segment: Insurance, through which it offers PPO and HMO plans to Medicare Advantage members in several states.